Table 1.
Health history of breast cancer survivors (N=59)
Treatment | Mean (SD) or % of Sample |
---|---|
Age | 58.5 (9.7) |
BMI (kg/m2) | 28.3 (7.2) |
Months since diagnosis | 20.9 (6.5) |
Stage 0 | 5% |
Stage I | 29% |
Stage II | 39% |
Stage III | 19% |
Chemotherapy only (N=17) | 29% |
Current adjuvant endocrine therapy (N=19) | |
SERM use only (N=7) | 12% |
Current AI use only (N=12) | 20% |
Chemotherapy + current SERM or AI use (N=23) | 39% |
Abbreviations: SERM: Selective estrogen receptor modulator; AI: Aromatase inhibitor